Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B GOTTLIEB

Showing results (361-370 of 523) with videos related to

Pageof 53
Sort By:
Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.
Dermatology and Therapy|September 16, 2024
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with PsoriasisMatthias Augustin, Alice B Gottlieb, Mark Lebwohl, et al.
The Journal of Clinical Investigation|February 1, 1986
Human keratinocyte culture. Identification and staging of epidermal cell subpopulationsL Staiano-Coico, P J Higgins, Z Darzynkiewicz, et al.
The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.
Nucleic Acids Research|February 21, 1998
The Nuclear Receptor Resource: a growing familyE Martinez, D D Moore, E Keller, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1984
Granuloma annulare. Identification of cells in the cutaneous infiltrate by immunoperoxidase techniquesR L Modlin, S A Vaccaro, B Gottlieb, et al.
Rheumatology (Oxford, England)|October 3, 2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 studyIain B McInnes, Philip J Mease, Christopher T Ritchlin, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized studyCarin Gribetz, Mark Ling, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|December 10, 2014
The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatologyAlice B Gottlieb, Adriane A Levin, April W Armstrong, et al.
Archives of Dermatology|August 1, 1991
Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathwaysL Khandke, J F Krane, R Ashinoff, et al.
Pageof 53

Showing results (361-370 of 523) with videos related to

Sort By:
Pageof 53
Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.
Dermatology and Therapy|September 16, 2024
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with PsoriasisMatthias Augustin, Alice B Gottlieb, Mark Lebwohl, et al.
The Journal of Clinical Investigation|February 1, 1986
Human keratinocyte culture. Identification and staging of epidermal cell subpopulationsL Staiano-Coico, P J Higgins, Z Darzynkiewicz, et al.
The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.
Nucleic Acids Research|February 21, 1998
The Nuclear Receptor Resource: a growing familyE Martinez, D D Moore, E Keller, et al.
Archives of Pathology & Laboratory Medicine|May 1, 1984
Granuloma annulare. Identification of cells in the cutaneous infiltrate by immunoperoxidase techniquesR L Modlin, S A Vaccaro, B Gottlieb, et al.
Rheumatology (Oxford, England)|October 3, 2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 studyIain B McInnes, Philip J Mease, Christopher T Ritchlin, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized studyCarin Gribetz, Mark Ling, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|December 10, 2014
The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatologyAlice B Gottlieb, Adriane A Levin, April W Armstrong, et al.
Archives of Dermatology|August 1, 1991
Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathwaysL Khandke, J F Krane, R Ashinoff, et al.
Pageof 53